Nivia Hernandez Ramos, MD
Neurology · Bayamon, PRNPI 1427243617
Payments from drug & device makers
Across 55 payments — averaging $24.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$332
- PBG Puerto Rico LLC$327
- Biohaven Pharmaceutical Holding Company Ltd.$146
- Biohaven Pharmaceuticals, Inc.$129
- Sunovion Pharmaceuticals Inc.$102
- AbbVie$81
- plus $218 from 4 others
What the payments were for
- Food & beverage$1,335100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $332 |
| PBG Puerto Rico LLC | 15 | $327 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $146 |
| Biohaven Pharmaceuticals, Inc. | 6 | $129 |
| Sunovion Pharmaceuticals Inc. | 5 | $102 |
| AbbVie | 3 | $81 |
| Eli Lilly Export S.A. Puerto Rico Branch | 4 | $73 |
| Johnson And Johnson International | 2 | $72 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| Bard Peripheral Vascular, Inc. | 1 | $23 |
How this compares
$1,335 in reported general payments places this provider in the 45th percentile of 129 neurology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rivastigmine | 103 | $12,847 |
| Nurtec OdtRimegepant Sulfate | 11 | $11,097 |
| AriceptDonepezil Hcl | 15 | $7,606 |
| Memantine Hcl ErMemantine Hcl | 89 | $6,574 |
| Donepezil Hcl | 669 | $5,958 |
| Galantamine ErGalantamine Hbr | 69 | $4,971 |
| Memantine Hcl | 249 | $4,621 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 97 | $3,571 |
| DilantinPhenytoin Sodium Extended | 13 | $2,012 |
| Gabapentin | 145 | $1,544 |
| Pregabalin | 51 | $924 |
| RivastigmineRivastigmine Tartrate | 15 | $766 |
| Temazepam | 33 | $672 |
| Diclofenac Potassium | 20 | $612 |
| Quetiapine Fumarate | 61 | $610 |
Paid to pharmacies, not to this prescriber.
Other neurology in Bayamon
- Horacio Daubon-Del ValleBayamon$21K
- Melissa Mendez MoralesBayamon$6K
- Nicolas Perez MaldonadoBayamon$5K
- Carlos Barreto MirandaBayamon$4K
- Olga RiosBayamon$4K
- Luis Rivera RamosBayamon$2K
- Rene Sanchez BorreroBayamon$2K
- Angel ChineaGuaynabo$13.3M
- Diana BalsalobreGuaynabo$2.5M
- Ivonne Fraga BerriosHato Rey$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.